BioTalentum Ltd has been established in 2005, and the leading Hungarian company in the field of human induced pluripotent stem cell based regenerative medicine, in vitro disease modelling and in vitro drug/chemical toxicity assays. BIOT is very active in international collaborations, including EU Framework projects (13 coordination of 30+ completed and ongoing projects, IHI and national projects). We have ongoing projects on T1D beta cell therapy (preclinical stage), and ASO gene therapy for ultra rare diseases. For details please visit www.biotalentum.eu .
Matching the "-Tool-03 and 06" calls: NAMs development and applications for biomedical research and testing of medicinal products/devices
Consortium/Coordinator seeks Partners
Partner seeks Consortium/Coordinator
DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Matching Tool-05, -07: Developing ATMPs for regenerative medicine solution on Type-1 diabetes
Consortium/Coordinator seeks Partners
Partner seeks Consortium/Coordinator
DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)